Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Myrexis, Inc. (MYRX)
USD0.00
+0.00 (+0.00%)
US OTC Financial Services Shell Companies
Address
630 Fifth Avenue 10020
New York City, NY, US
New York City, NY, US
CEO
Jonathan Couchman
Website
myrexis.com
IPO
2009-06-12
ISIN US62856H1077
Description
Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially backing ventures within the life sciences sector. The company, which now operates under the name Myrexis, Inc., was previously known as Myriad Pharmaceuticals, Inc. until its rebranding took place in July 2010. Its main corporate offices are situated in New York, New York.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
471
Beta
3.57
Float Shares
25.64M
Free Float %
74.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -11.11% | -11.11% | +100.00% | +33.33% | +166.67% | +100.00% | -87.88% | -55.56% | -98.40% | -98.55% | -99.99% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
DCF (Unlevered)
0.04
+4,645.5%
DCF (Levered)
0.04
+4,645.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-177.01
Distress
Piotroski F-Score
0 / 9
Weak
MOAT Score
1 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Shell Companies: +20.6%—
-
EPS growth Shell Companies: -12.3%+67.0% ★ Q2'13: +10.2% (vs Q2'12)
-
FCF margin FCF growth · Shell Companies: +8.7%—
-
EBIT margin Shell Companies: +0.0%—
-
ROIC Shell Companies: +0.0%— Q2'13: +1,302.1% (vs Q2'12)
-
Share dilution Shell Companies: -10.2%+13.3% Q2'13: +12.4% (vs Q2'12)
-
Debt / EBITDA Net debt/EBITDA · Shell Companies: 0.00×0.00× Q2'13: 0.00× (vs Q2'12)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-12.97M
OE per share TTM
-0.47
Owner's Yield
-54,236.21%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
22.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-01-22 | COUCHMAN JONATHAN | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2013-01-18 | HENDERSON JOHN T | Director | M-Exempt | A | Common Stock | 2,500 | 0.95 | 2.4K | 33,500 | — | ↗ |
| 2012-06-18 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 3,000 | 2.29 | 6.9K | 545,245 | — | ↗ |
| 2012-06-15 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 1,025 | 2.35 | 2.4K | 542,245 | — | ↗ |
| 2012-06-14 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 4,000 | 2.36 | 9.5K | 541,220 | — | ↗ |
| 2012-06-07 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 1,116 | 2.40 | 2.7K | 537,220 | — | ↗ |
| 2012-05-31 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 10,133 | 2.35 | 23.8K | 536,104 | — | ↗ |
| 2012-05-30 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 4,020 | 2.47 | 9.9K | 525,971 | — | ↗ |
| 2012-05-25 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 153 | 2.47 | 377.91 | 521,951 | — | ↗ |
| 2012-05-23 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 1,000 | 2.47 | 2.5K | 521,798 | — | ↗ |
| 2012-05-22 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 262 | 2.46 | 644.52 | 520,798 | — | ↗ |
| 2012-05-21 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 12,000 | 2.51 | 30.1K | 520,536 | — | ↗ |
| 2012-05-18 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 7,168 | 2.60 | 18.6K | 508,536 | — | ↗ |
| 2012-05-17 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 3,832 | 2.61 | 10.0K | 501,368 | — | ↗ |
| 2012-05-16 | Belle Gerald P. | Director | P-Purchase | A | Common Stock | 27,700 | 2.74 | 75.8K | 77,230 | — | ↗ |
| 2012-05-15 | Belle Gerald P. | Director | P-Purchase | A | Common Stock | 8,930 | 2.74 | 24.4K | 49,530 | — | ↗ |
| 2012-03-17 | Aryeh Jason | Director | X-InTheMoney | A | Common Stock | 2,000 | 5.00 | 10.0K | 497,536 | — | ↗ |
| 2012-01-31 | Aryeh Jason | Director | X-InTheMoney | A | Common Stock | 9,500 | 5.00 | 47.5K | 495,536 | — | ↗ |
| 2011-12-17 | Aryeh Jason | Director | X-InTheMoney | A | Common Stock | 22,000 | 5.00 | 110.0K | 483,036 | — | ↗ |
| 2011-12-08 | HENDERSON JOHN T | Director | A-Award | A | Director Stock Option (Right to Buy) | 16,250 | 2.82 | 45.8K | 16,250 | — | ↗ |
| 2011-12-08 | Franson Timothy R | Director | A-Award | A | Director Stock Option (Right to Buy) | 16,250 | 2.82 | 45.8K | 16,250 | — | ↗ |
| 2011-12-08 | Forrester Robert | Director | A-Award | A | Director Stock Option (Right to Buy) | 16,250 | 2.82 | 45.8K | 16,250 | — | ↗ |
| 2011-12-08 | Belle Gerald P. | Director | A-Award | A | Director Stock Option (Right to Buy) | 16,250 | 2.82 | 45.8K | 16,250 | — | ↗ |
| 2011-12-05 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 30,792 | 2.75 | 84.8K | 461,036 | — | ↗ |
| 2011-12-02 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 27,600 | 2.69 | 74.3K | 430,244 | — | ↗ |
| 2011-12-01 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 42,618 | 2.65 | 112.9K | 402,644 | — | ↗ |
| 2011-11-30 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 9,900 | 2.61 | 25.8K | 9,900 | — | ↗ |
| 2011-11-29 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 91,800 | 2.58 | 236.7K | 360,026 | — | ↗ |
| 2011-11-28 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 64,805 | 2.55 | 165.5K | 268,226 | — | ↗ |
| 2011-11-25 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 41,956 | 2.51 | 105.3K | 203,421 | — | ↗ |
| 2011-11-23 | Belle Gerald P. | Director | P-Purchase | A | Common Stock | 6,100 | 2.48 | 15.1K | 40,600 | — | ↗ |
| 2011-11-23 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 25,499 | 2.50 | 63.6K | 161,465 | — | ↗ |
| 2011-11-22 | Belle Gerald P. | Director | P-Purchase | A | Common Stock | 34,200 | 2.48 | 84.6K | 34,500 | — | ↗ |
| 2011-11-22 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 53,700 | 2.47 | 132.6K | 135,966 | — | ↗ |
| 2011-11-19 | Aryeh Jason | Director | X-InTheMoney | A | Common Stock | 1,000 | 7.50 | 7.5K | 82,266 | — | ↗ |
| 2011-11-14 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 9,700 | 2.64 | 25.6K | 81,266 | — | ↗ |
| 2011-11-11 | Aryeh Jason | Director | P-Purchase | A | Common Stock | 2,500 | 2.65 | 6.6K | 71,566 | — | ↗ |
| 2011-11-03 | Aryeh Jason | Director | X-InTheMoney | D | Put Option (Obligation to Buy) | 12 | 5.00 | 60.00 | 220 | — | ↗ |
| 2011-10-19 | Aryeh Jason | Director | A-Award | A | Director Stock Option (Right to Buy) | 25,000 | 2.74 | 68.5K | 25,000 | — | ↗ |
| 2010-11-11 | HENDERSON JOHN T | Director | A-Award | A | Director Stock Option (Right to Buy) | 16,250 | 3.71 | 60.3K | 16,250 | — | ↗ |
| 2010-11-11 | Franson Timothy R | Director | A-Award | A | Director Stock Option (Right to Buy) | 16,250 | 3.71 | 60.3K | 16,250 | — | ↗ |
| 2010-11-11 | Forrester Robert | Director | A-Award | A | Director Stock Option (Right to Buy) | 16,250 | 3.71 | 60.3K | 16,250 | — | ↗ |
| 2010-11-11 | Belle Gerald P. | Director | A-Award | A | Director Stock Option (Right to Buy) | 16,250 | 3.71 | 60.3K | 16,250 | — | ↗ |
| 2009-09-10 | Franson Timothy R | Director | A-Award | A | Director Stock Option (Right to Buy) | 25,000 | 4.63 | 115.8K | 25,000 | — | ↗ |
| 2009-07-01 | HENDERSON JOHN T | Director | A-Award | A | Director Stock Option (Right to Buy) | 25,000 | 4.03 | 100.8K | 25,000 | — | ↗ |
| 2009-07-01 | Forrester Robert | Director | A-Award | A | Director Stock Option (Right to Buy) | 25,000 | 4.03 | 100.8K | 25,000 | — | ↗ |
| 2009-07-01 | Belle Gerald P. | Director | A-Award | A | Director Stock Option (Right to Buy) | 25,000 | 4.03 | 100.8K | 25,000 | — | ↗ |
| 2009-06-11 | HENDERSON JOHN T | Director | — | D | No securities are beneficially owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2009-06-11 | Forrester Robert | Director | — | D | No securities are beneficially owned. | 0 | 0.00 | — | 0 | — | ↗ |
| 2009-06-11 | Belle Gerald P. | Director | — | D | No securities are beneficially owned. | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
34.48M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jonathan Couchman | Chairman, Chief Executive Officer, President, Chief Financial Officer & Principal Accounting Officer | 1 | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MYRX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
